Hims & Hers Health Inc. (HIMS) saw its stock soar 9.34% in Wednesday's trading session, following the release of encouraging early results from its digital-first GLP-1 weight loss program. The telehealth company's shares jumped on news that participants in the program experienced significant weight loss and high adherence rates.

According to the data shared by Hims & Hers, users of their personalized weight loss platform lost an average of 20.9 pounds, or over 10% of their starting weight, within six months. The company reported an impressive 75% retention rate at the six-month mark, significantly outperforming typical dropout rates for similar medications. Additionally, only 10.3% of users reported side effects, with less than 5% discontinuing treatment due to severe symptoms.

The success of the program is attributed to its comprehensive approach, which combines personalized dosing, 24/7 provider access, and holistic health support. Dr. Craig Primack, Head of Weight Loss at Hims & Hers, emphasized that while medication is part of the solution, the tailored support in various aspects of health is what truly drives results. The positive outcomes and the potential for growth in the weight loss market have clearly resonated with investors, leading to the significant stock price increase.